Moxifloxacin hydrochl and 4 more items

The Defense Logistics Agency Troop Support Medical is soliciting quotes under request for quotation SPE2DP27T0316 for moxifloxacin hydrochloride, five line items totaling 28 bottles, with quotes due November 18, 2026. The procurement carries no set-aside, as the notice's Set Aside line reads "No Set-Aside Used," and it is issued through DIBBS as a Fast Auto Evaluation solicitation. The NSN is 6505-01-503-4772, and the PSC is 6505, Drugs and Biologicals.

Line quantities are 5, 8, 7, 5, and 3 bottles, each with delivery within 20 days. Terms are FOB Destination with inspection at destination. Quotes must be submitted electronically via DIBBS.

The attached RFQ summary states that the item is FDA-regulated and requires a referral to DLA's product specialist before award, including bidder and manufacturer information. It lists approved manufacturers as Rising Pharma Holdings, Inc. (CAGE 8FG82, NDC57237-0156-30) and Teva Pharmaceuticals USA, Inc. (CAGE 3V8D7, NDC00093-7387-56). Packaging must comply with MIL-STD-129 and Medical Marking Standard No. 1, and shelf life must be 36 months, non-extendable. The summary also states that DFARS Buy American requirements apply to quotes above the micro-purchase threshold.

Pricing is quoted per bottle. The same summary reports recent awards for this NSN at unit prices from approximately $51.77 to $78.99 per bottle. The notice does not state an evaluation weighting, a ceiling, or an incumbent.